Janssen Global Services LLC - Company Review
Janssen Global Services LLC - Company ReviewSummary
Janssen Global Services LLC (JGS), a subsidiary of Johnson & Johnson is a developer and supplier of medicines for various therapeutic areas. The company’s products include almotriptan malates, doxorubicin HCl liposome injection, fentanyl transdermal system, methylphenidate HCL, oxybutynin chloride, rilpivirine, pentosan polysulfate sodium, haloperidol, ibrutinib, etravirine, estradiol, and ethinyl estradiol + norelgestromin, among others. It provides products for various target therapy areas such as cardiovascular and metabolism; immunology, infectious diseases and vaccines; neuroscience and oncology. JGS’ research areas comprise novel approaches to disease prevention, disease interception and the microbiome areas. The company operates through its offices in Titusville, Raritan and Horsham, the US. JGS is headquartered in Titusville, New Jersey, the US.
This comprehensive company report of Janssen Global Services LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.